Prg Science & Technology Co., Ltd.
Clinical trials sponsored by Prg Science & Technology Co., Ltd., explained in plain language.
-
New hope for NF2: experimental drug aims to shrink tumors and save hearing
Disease control Not yet recruitingThis early-stage trial tests a daily drug called PRG-N-01 in 25 adults with neurofibromatosis type II (NF2), a genetic condition that causes non-cancerous tumors on nerves, often leading to hearing loss. The study aims to find the safest and most effective dose, and to see if the…
Phase: PHASE1, PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New hope for rare aging disease: drug targets bone loss
Disease control Not yet recruitingThis study tests a drug called Progerinin in up to 5 adults with Werner syndrome, a rare condition that causes premature aging and bone loss. The goal is to see if the drug is safe and tolerable when taken twice daily for about a year. Participants must have confirmed Werner synd…
Phase: PHASE2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC